Existing investors have invested a further €18m in Spanish biopharma Cellerix, prior to its merger with Belgium-based TiGenix.
H2 Equity reinvests with minority share; sale saw interest from Partners, HIG, CapVest
With a EUR 300m hard cap, the fund could complete its first investment by H1 2023
Sale of parent company of specialist outdoor brands Rab and Lowe Alpine is the firm’s third exit this year
Energy sector investor prepares to raise EUR 350m for Article 9 fund targeting renewable, clean tech businesses